Pharma Journalist 8791 posts 0 comments

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced that the Committee for Medicinal Products for Human Use (CHMP) of…
Read More...

SMi reports: The upcoming Pain Therapeutics conference, taking place on the 13th and 14th May 2019, will gather expert speakers to address several industry-led themes. SMi’s Pain…
Read More...

To meet the growing needs of the market, Cardinal Health Specialty Solutions has strengthened its cell and gene therapy capability with a coordinated suite of specialty distribution,…
Read More...

GSK announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of Benlysta (belimumab), a B-lymphocyte…
Read More...

The European Commission has granted marketing authorization for Zynquista (sotagliflozin)*, developed by Sanofi and Lexicon. Zynquista is now approved in the European Union, at…
Read More...

Regeneron Pharmaceuticals and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Praluent (alirocumab) to reduce the risk of heart attack, stroke and…
Read More...

Lonza announced the global availability of the world’s first fully automated and integrated plate-based PyroTec PRO Robotic Solution for endotoxin testing. Combining the speed and…
Read More...

Gilead Sciences announced that STELLAR-3, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib, an investigational, once…
Read More...

ACADIA Pharmaceuticals Inc. announced the initiation of the Phase 3 CLARITY-2 study and plans to initiate the Phase 3 CLARITY-3 study in the upcoming months. These studies will evaluate…
Read More...

Salix Pharmaceuticals and a wholly owned subsidiary of Bausch Health Companies Inc. announced that its affiliate has entered into an exclusive licensing agreement with Mitsubishi Tanabe…
Read More...